Alcon announces MARLO updates with anticipated unveiling of new app at SECO 2024
February 27th 2024The eye care device company has announced that MARLO has gone mobile with a new app, which allows patients to order contact lenses, perform vision screening, and access eye disease and care information.
IKA Keratoconus Symposium to bring "best of the best"
Andrew S. Morgenstern, OD, FAAO, FNAP sits down with Optometry Times to reiterate under-utilized diagnostic tools for keratoconus and the planning of this year's International Keratoconus Academy Keratoconus Symposium, running from May 18-19 in Bethesda, Maryland.
Opthea Limited completes enrollment for 1 of 2 Phase 3 sozinibercept (OPT-302) trials
February 19th 2024The clinical-stage biopharmaceutical company is running 2 Phase 3 clinical trials, COAST and ShORe, to assess the efficacy and safety of using combinations of certain drugs to treat wet age-related macular degeneration.
G360 2024: Rehashing glaucoma treatments with Dr Michael Chaglasian
Optometry Times chats with Michael Chaglasian, OD, FAAO during this year's Glaucoma 360 meeting in San Francisco, California.
EnVision Summit 2024: Family time and eye care take center stage
Cecelia Koetting, OD, FAAO, DIPABO chats with Optometry Times about her role with EnVision Summit's new optometry program and the excitement surrounding the event.
What to look out for and how to treat central serous chorioretinopathy
William Hogue, OD, MS, sat down with Optometry Times to outline what symptoms and risk factors eye care providers should look out for in identifying central serous chorioretinopathy in their patients, as well as what treatment options are available.
Bonnie An Henderson, MD, cofounder of EnVision Summit, sits down with Optometry Times to detail the upcoming event that takes a unique, family-friendly approach to centering diversity in the eye care profession.
Nighttime outdoor artificial light may increase risk of age-related macular degeneration
January 19th 2024A new case-control study found that older people ages 70 and older living in South Korea’s urban areas were at a significantly higher risk for developing incident exudative age-related macular degeneration.